injection ghk cu Peptide and GHK GHK-CU - Beverly Hills Rejuvenation

Ultimately, 706 participants met the eligibility criteria and were randomly assigned to one of several treatment arms: once-weekly subcutaneous injections of Cagrilintide at doses of 0.3, 0.6, 1.2, 2.4, or 4.5 mg, once-daily liraglutide 3.0 mg, or a volume-matched placebo

PMID 33159471

The procedure is typically done on an outpatient basis, meaning you can return home the same day

Proteomics and metabolomics revealed a downregulation of aerobic respiration and altered glucose metabolism in plasma of patients receiving 100mg C+P which was not detected in lower dosages

Adequate vitamin D (2000 to 5000 IU daily for most people) supports bone health and immune function

doi: 10.1016/j.cellimm.2011.05.001